Enliven Therapeutics Inc (ELVN)

Currency in USD
44.775
+1.085(+2.48%)
Real-time Data·
Advertisement

Enliven Therapeutics (ELVN) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy

Technical Indicators

Strong Buy

Moving Averages

Strong Buy

Summary:Strong Buy

Moving Averages:Strong BuyBuy: (12)Sell: (0)
Technical Indicators:Strong BuyBuy: (8)Sell: (0)

Technical Indicators

Summary: Strong BuyBuy: 8Neutral: 0Sell: 0
Oct 28, 2026 15:41 GMT
Name
Value
Action
RSI(14)72.400Buy
STOCH(9,6)97.746Overbought
STOCHRSI(14)87.714Overbought
MACD(12,26)0.882Buy
ADX(14)34.170Buy
Williams %R-3.367Overbought
CCI(14)95.2568Buy
ATR(14)0.6401Less Volatility
Highs/Lows(14)1.8700Buy
Ultimate Oscillator69.196Buy
ROC8.902Buy
Bull/Bear Power(13)2.3937Buy

Moving Averages

Summary: Strong BuyBuy: 12Sell: 0
Oct 28, 2026 15:41 GMT
Name
Simple
Exponential
MA5
44.266
Buy
44.386
Buy
MA10
43.947
Buy
43.836
Buy
MA20
42.634
Buy
43.079
Buy
MA50
41.690
Buy
42.017
Buy
MA100
40.742
Buy
42.044
Buy
MA200
43.380
Buy
44.333
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic43.66043.91544.37044.62545.08045.33545.790
Fibonacci43.91544.18644.35444.62544.89645.06445.335
Camarilla44.63044.69544.76044.62544.89044.95545.020
Woodie's43.76043.96544.47044.67545.18045.38545.890
DeMark's--44.49744.68945.207--

FAQ

Is Enliven Therapeutics (ELVN) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Enliven Therapeutics buy/sell signal is Strong Buy.

What Do The Current Moving Averages for Enliven Therapeutics (ELVN) Show?

The moving averages for Enliven Therapeutics show a Buy outlook, considering moving averages ranging from MA5 to MA200, with 8 Buy signals and 4 Sell signals.

What Do Today's Technical Indicators for Enliven Therapeutics Show?

The technical indicators for Enliven Therapeutics are in a Strong Buy position based on daily analysis, with 6 signals on buy indicators and 1 sell signals.

What Is Enliven Therapeutics (ELVN)'s 14-Day RSI?

The current Relative Strength Index (RSI) of ELVN over the 14-day period is 72.400, which suggests that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s MACD?

ELVN's MACD (Moving Average Convergence/Divergence) is 0.882, which suggests that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 5-Day Moving Average?

ELVN's 5-day moving average is 44.266, suggesting that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 50-Day Moving Average?

ELVN's 50-day moving average is 41.690, suggesting that the stock is a Buy.

What Is Enliven Therapeutics (ELVN)'s 200-Day Moving Average?

ELVN's 200-day moving average is 43.380, suggesting that the stock is a Buy.

What Is the Fibonacci Pivot Point Performance Value for Enliven Therapeutics (ELVN)?

The Fibonacci pivot point performance value for ELVN is 44.625.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.